TY - CHAP M1 - Book, Section TI - Therapeutic Apheresis: Indications, Efficacy, and Complications A1 - Weinstein, Robert A2 - Kaushansky, Kenneth A2 - Lichtman, Marshall A. A2 - Prchal, Josef T. A2 - Levi, Marcel M. A2 - Press, Oliver W. A2 - Burns, Linda J. A2 - Caligiuri, Michael Y1 - 2015 N1 - T2 - Williams Hematology, 9e AB - SUMMARYTherapeutic apheresis refers to several blood processing methods that are used in the treatment of diverse clinical conditions. In most cases, the disorders so treated are characterized by a specific qualitative or quantitative abnormality of the blood. In hematologic practice, apheresis procedures are used to mitigate hyperviscosity in monoclonal protein disorders or remove pathologic autoantibodies and replete important plasma proteins. Red cell apheresis is used to improve the ratio of normal to abnormal red cells in hemoglobinopathies and protozoan disease, and to remove excess red cells, red cell-associated toxins, or excess iron from the body. Leukocyte apheresis is used to reduce the circulating blast count in acute leukemias with hyperleukocytosis and platelet apheresis is used to lower a very elevated platelet count in patients with myeloproliferative neoplasms. Photopheresis is used in the treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease. Adverse effects of apheresis with current technologies are typically mild and, usually, do not prevent completion of therapy. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/10/06 UR - hemonc.mhmedical.com/content.aspx?aid=1121091024 ER -